Greensignal Bio Pharma Ltd. - Research Center

---

Results

• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Capital structures
• Ratio

Mar ' 16	Mar ' 15	Mar ' 14	Mar ' 13	Mar ' 12

Sources of funds

Owner's fund

Equity share capital

15.35

13.57

13.57

13.57

13.57

Share application money

-

-

-

7.62

6.98

Preference share capital

-

-

-

-

-

Reserves & surplus

39.72

22.00

22.21

23.51

24.01

Loan funds

Secured loans

5.58

3.92

3.98

6.59

9.35

Unsecured loans

-

-

-

0.02

0.02

Total

60.65

39.49

39.77

51.31

53.94

Uses of funds

Fixed assets

Gross block

38.92

39.80

36.49

37.61

38.68

Less : revaluation reserve

1.66

1.66

-

-

-

Less : accumulated depreciation

-

-

-

-

-

Net block

37.26

38.13

36.49

37.61

38.68

Capital work-in-progress

11.47

11.60

11.24

10.01

8.50

Investments

-

-

-

-

-

Net current assets

Current assets, loans & advances

18.95

7.28

9.22

6.25

10.00

Less : current liabilities & provisions

7.03

17.51

17.18

2.57

3.24

Total net current assets

11.92

-10.24

-7.96

3.69

6.76

Miscellaneous expenses not written

-

-

-

-

-

Total

60.65

39.49

39.77

51.31

53.94

Notes:

Book value of unquoted investments

-

-

-

-

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

-

-

-

-

Number of equity sharesoutstanding (Lacs)

153.47

135.73

135.73

135.73

135.73